Skip to main content

Pettiti Gianluca's Form 4 filing

Thermo Fisher Scientific Inc.TMO · filed Nov 16, 2026

Accession no.
0000097745-26-000184
Filed
Nov 16, 2026, 4:52 PM ET
Trade date
Nov 13, 2026
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.90M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pettiti GianlucaCIK 0001844600Officer (President & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2026Common StockSSaleDisposed−400$701.42−$280,56822,816.14Direct
Nov 13, 2026Common StockMOption exerciseAcquired+3,733$309.63+$1,155,848.7926,549.14Direct
Nov 13, 2026Common StockSSaleDisposed−3,733$701.42−$2,618,400.8622,816.14Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 13, 2026Common StockMOption exerciseDisposed−3,733$0.00$03,734Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)